We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DETAILS PROGRESS ON CTD, MedDRA PRIOR TO ICH MEETING
FDA DETAILS PROGRESS ON CTD, MedDRA PRIOR TO ICH MEETING
May 18, 2004
FDA officials reported progress on key International Conference on Harmonisation (ICH) initiatives at a public meeting yesterday to prepare participants for the ICH Steering Committee and Experts Working Groups meetings slated for June 7-10 in Washington, D.C.